Table 3 Baseline clinical characteristics of patients in the maintained sinus rhythm (MSR) group as compared to the atrial fibrillation recurrence (AFR) group
| Â | MSR (27) n (%) | AFR (14) n (%) | P value |
|---|---|---|---|
Mean age (years) | 65 ± 5.0 | 64 ± 6.8 | 0.9 |
Sex (M/F) | 21/6 | 8/6 | 0.28 |
BMI (Kg/m2) | 32 ± 3.0 | 34 ± 3.6 | 0.26 |
Comorbid conditions: | Â | Â | Â |
HTN | 21 (77.8) | 12 (85.7) | 0.69 |
CAD | 9 (33.3) | 5 (35.7) | 1.0 |
Systolic HF | 11 (40.7) | 3 (21.4) | 0.3 |
CVA | 0 (0) | 1 (7.1) | 0.34 |
DM | 5 (18.5) | 6 (42.8) | 0.14 |
Dyslipidemia | 16 (59.2) | 8 (57.1) | 1.0 |
Medications: | Â | Â | Â |
Statins | 14 (51.8) | 8 (57.1) | 1.0 |
Beta blockers | 20 (74.1) | 7 (50.0) | 0.17 |
ACE-i/ARB | 14 (51.8) | 11 (78.5) | 0.17 |
CCB | 12 (44.5) | 6 (42.8) | 1.0 |
Digoxin | 2 (7.4) | 2 (14.3) | 0.59 |
Diuretics | 16 (59.2) | 5 (35.7) | 0.19 |
ASA | 18 (66.7) | 12 (85.7) | 0.28 |
Clopidogrel | 1 (3.7) | 1 (7.1) | 1.0 |
Warfarin | 18 (66.7) | 10 (71.4) | 1.0 |
Heparin | 1 (3.7) | 3 (21.4) | 0.11 |
Amiodarone | 7 (25.9) | 1 (7.1) | 0.23 |
Sotalol | 2 (7.4) | 3 (21.4) | 0.32 |
Other anti-arrhythmics | 3 (11.1) | 1 (7.1) | 1.0 |